Product Launch of the Next Generation of the ADVOS System
09.08.2024 Munich – Invitation to the product launch of the next generation of the ADVOS system! Join the event! In 117 days, the time has
For journalists, a precise overview and up-to-date news are essential for their daily work. Our press area offers you information on what is happening around ADVITOS and an overview of press releases on our current topics. Find out about current developments here and use the direct contact to your contacts in our company.
09.08.2024 Munich – Invitation to the product launch of the next generation of the ADVOS system! Join the event! In 117 days, the time has
11.05. 2023 – 12.05.2023 Munich – ADVOS user conference at Schloss Hohenkammer brings together medical professionals from numerous clinics for the first time to share
20.06.2022 – 25.06.2022 We had the privilege of participating in the Scaling Impact Executive Education Programme at Católica Lisbon School of Business and Economics. Together
01.06.2022 Munich – ADVITOS GmbH appoints new CEO and reveals future plans for growth ADVITOS GmbH is well-known for its breakthrough innovation in the medical
27.01.2022 Munich – ADVITOS grows by new competences and capacities in three positions ADVITOS enjoys a well-earned reputation in the field of medical technology on
04.10.2021 On 7 October, we are one of the 15 finalists taking the stage in Lisbon to pitch our project for a chance to win
13.07.2021 Munich – The city of Munich has awarded the “LaMonachia” prize for the third time. The business award for women honors successful female managers
14.05.2021 Munich – ADVITOS GmbH has been selected by the EIB Institute as one of the 15 best social entrepreneurs out of 280 applicants from
24.11.2020 Munich – The Munich-based medical technology company was selected from 189 nominations by an independent jury and won the 1st main prize The Bavarian
30.06.2020 Munich – ADVITOS, which received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 880349, is one of